Generation of Monoclonal Antibodies Against Human Prion Proteins in PrP0/0 Mice

Overview

Journal Mol Med

Publisher Biomed Central

Specialties General Medicine
Molecular Biology

Date 1996 Nov 1

PMID 8972487

Citations 46

Authors

S Krasemann

M H Groschup

S Harmeyer

G Hunsmann

W Bodemer

Affiliations

Soon will be listed here.

Abstract

Background: Prion diseases belong to a group of neurodegenerative disorders affecting humans and animals. The human diseases include kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), and fatal familial insomnia (FFI). The pathogenic mechanisms of the prion diseases are not yet understood. Monoclonal antibodies provide valuable tools in the diagnosis, as well as in the basic research, of several diseases; however, monospecific antisera or monoclonal antibodies (mAbs) against human prion proteins were, until now, not available.

Materials And Methods: We have developed an immunization protocol based on nucleic acid injection into nontolerant PrP0/0 mice. DNA or RNA coding for different human prion proteins including the mutated sequences associated with CJD, GSS, and FFI were injected into muscle tissue. Mice were primarily inoculated with DNA plasmids encoding the prion protein (PRNP) gene and boosted either with DNA, RNA, or recombinant Semliki Forest Virus particles expressing PRNP. Hybridomas were then prepared.

Results: Different mAbs against human prion proteins were obtained, and their binding behavior was analyzed by peptide enzyme-linked immunosorbent assay, Western blot, immunofluorescence, and immunoprecipitation. Their cross-reactivity with prion protein from other species was also determined. Our mAbs are directed against four different linear epitopes and may also recognize discontinuous regions of the native prion protein.

Conclusions: These antibodies should allow us to address questions concerning the nature of the prion protein as well as the initiation and progression of prion diseases. Moreover, these mAbs can now be used for the diagnosis of prion diseases of humans and animals.

Citing Articles

Conventional and State-of-the-Art Detection Methods of Bovine Spongiform Encephalopathy (BSE).

Olech M Int J Mol Sci. 2023; 24(8).

PMID: 37108297 PMC: 10139118. DOI: 10.3390/ijms24087135.

Vaccines for prion diseases: a realistic goal?.

Napper S, Schatzl H Cell Tissue Res. 2023; 392(1):367-392.

PMID: 36764940 PMC: 9918406. DOI: 10.1007/s00441-023-03749-7.

Host prion protein expression levels impact prion tropism for the spleen.

Beringue V, Tixador P, Andreoletti O, Reine F, Castille J, Lai T PLoS Pathog. 2020; 16(7):e1008283.

PMID: 32702070 PMC: 7402522. DOI: 10.1371/journal.ppat.1008283.

Pathologic and biochemical characterization of PrP from elk with PRNP polymorphisms at codon 132 after experimental infection with the chronic wasting disease agent.

Moore S, Vrentas C, Hwang S, Greenlee M, Nicholson E, Greenlee J BMC Vet Res. 2018; 14(1):80.

PMID: 29523205 PMC: 5845354. DOI: 10.1186/s12917-018-1400-9.

Detection of PrP and prion infectivity in the ileal Peyer's patch of young calves as early as 2 months after oral challenge with classical bovine spongiform encephalopathy.

Ackermann I, Balkema-Buschmann A, Ulrich R, Tauscher K, Shawulu J, Keller M Vet Res. 2017; 48(1):88.

PMID: 29258602 PMC: 5738053. DOI: 10.1186/s13567-017-0495-5.

References

Brown P, Pomeroy K, Franko M, Asher D, Gibbs Jr C, Gajdusek D . Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med. 1986; 314(9):547-51. DOI: 10.1056/NEJM198602273140904. View

Krasemann S, Zerr I, Weber T, Poser S, Kretzschmar H, Hunsmann G . Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. Brain Res Mol Brain Res. 1995; 34(1):173-6. DOI: 10.1016/0169-328x(95)00175-r. View

Robakis N, Jenkins E, Kascsak R, Brown W, Krawczun M, Silverman W . Localization of a human gene homologous to the PrP gene on the p arm of chromosome 20 and detection of PrP-related antigens in normal human brain. Biochem Biophys Res Commun. 1986; 140(2):758-65. DOI: 10.1016/0006-291x(86)90796-5. View

Kascsak R, Rubenstein R, Merz P, Fersko R, Carp R, Wisniewski H . Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol. 1987; 61(12):3688-93. PMC: 255980. DOI: 10.1128/JVI.61.12.3688-3693.1987. View

Barry R, Vincent M, Kent S, HOOD L, Prusiner S . Characterization of prion proteins with monospecific antisera to synthetic peptides. J Immunol. 1988; 140(4):1188-93. View

Gabizon R, McKinley M, Groth D, Prusiner S . Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc Natl Acad Sci U S A. 1988; 85(18):6617-21. PMC: 282028. DOI: 10.1073/pnas.85.18.6617. View

DAlbis A, COUTEAUX R, Janmot C, Mira J . Myosin isoform transitions in regeneration of fast and slow muscles during postnatal development of the rat. Dev Biol. 1989; 135(2):320-5. DOI: 10.1016/0012-1606(89)90182-6. View

Gabizon R, Prusiner S . Prion liposomes. Biochem J. 1990; 266(1):1-14. PMC: 1131089. DOI: 10.1042/bj2660001. View

Brown P, Goldfarb L, Gajdusek D . The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist. Lancet. 1991; 337(8748):1019-22. DOI: 10.1016/0140-6736(91)92670-w. View

10.

Prusiner S . Molecular biology of prion diseases. Science. 1991; 252(5012):1515-22. DOI: 10.1126/science.1675487. View

11.

Liljestrom P, Garoff H . A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (N Y). 1991; 9(12):1356-61. DOI: 10.1038/nbt1291-1356. View

12.

Gibbs Jr C, Gajdusek D, Asher D, Alpers M, Beck E, Daniel P . Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science. 1968; 161(3839):388-9. DOI: 10.1126/science.161.3839.388. View

13.

Kearney J, Radbruch A, Liesegang B, Rajewsky K . A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol. 1979; 123(4):1548-50. View

14.

Prusiner S . Novel proteinaceous infectious particles cause scrapie. Science. 1982; 216(4542):136-44. DOI: 10.1126/science.6801762. View

15.

Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp H, DeArmond S . Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 1992; 356(6370):577-82. DOI: 10.1038/356577a0. View

16.

Ulmer J, Donnelly J, Parker S, Rhodes G, Felgner P, Dwarki V . Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 1993; 259(5102):1745-9. DOI: 10.1126/science.8456302. View

17.

Bueler H, Aguzzi A, Sailer A, Greiner R, Autenried P, Aguet M . Mice devoid of PrP are resistant to scrapie. Cell. 1993; 73(7):1339-47. DOI: 10.1016/0092-8674(93)90360-3. View

18.

Berglund P, Sjoberg M, Garoff H, Atkins G, Sheahan B, Liljestrom P . Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Biotechnology (N Y). 1993; 11(8):916-20. DOI: 10.1038/nbt0893-916. View

19.

Prusiner S, Groth D, Serban A, Koehler R, Foster D, Torchia M . Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A. 1993; 90(22):10608-12. PMC: 47826. DOI: 10.1073/pnas.90.22.10608. View

20.

Pan K, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D . Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A. 1993; 90(23):10962-6. PMC: 47901. DOI: 10.1073/pnas.90.23.10962. View